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HYALURONAN RAFTS ON AIRWAY EPITHELIAL CELLS 
 
AMINA M. ABBADI 
 
 
ABSTRACT 
 
Many cells, including murine airway epithelial cells, respond to a variety of 
inflammatory stimuli by synthesizing leukocyte-adhesive hyaluronan cables that 
remain attached to their cell surfaces. This study shows that air-liquid interface 
cultures of murine airway epithelial cells (AECs) also actively synthesize and release a 
majority of their HA onto their ciliated apical surfaces to form a heavy chain-
hyaluronan (HC-HA) matrix in the absence of inflammatory stimuli.  These matrices 
do not resemble the rope-like HA cables, but occur in distinct sheets, or rafts, that can 
capture and embed leukocytes from cell suspensions. The HC-HA modification 
involves the transfer of heavy chains from the inter-α-inhibitor (IαI) proteoglycan, 
which has 2 heavy chains (HC1 and HC2) on its chondroitin sulfate (CS) chain. The 
tranesterification transfer of HCs from CS to HA is mediated by tumor-necrosis-
factor-induced-gene 6 (TSG-6), which is upregulated in inflammatory reactions. 
Because the AEC cultures do not have TSG-6 nor serum, which is the source of IαI, 
assays for HCs and TSG-6 were done and showed that AECs synthesize TSG-6 and 
their own heavy chain donor (pre-IαI) with a single heavy chain 3 (HC3), which is the 
substrate for transfer to HA to form the H3-HA rafts. This HC3 pre-IαI is also 
constitutively expressed by human renal proximal tubular epithelial cells. These 
leukocyte adhesive HC3-HA structures were also found in the bronchoalveolar lavage 
(BAL) of naïve mice, and were observed on their apical ciliated surfaces.  Thus, these 
	  	  	   viii	  
leukocyte-adhesive HA rafts are now identified as HC3-HA complexes that could be 
part of a host defense mechanism filling some important gaps in our current 
understanding of murine airway epithelial biology and secretions.  
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ABBREVIATIONS 
 
 
 
Extracellular matrix (ECM), GlycosAminoGlycan (GAG) Inter-alpha-inhibitor (IαI), 
Heavy Chain (HC), hyaluronan (HA), Tumor-Necrosis-Factor-stimulated-gene-6 (TSG-
6), Tumor necrosis factor α induced protein-6 (Tnfaip6), Fluorophore-Assisted-
Carbohydrate-Electrophoresis (FACE), Airway Epithelial Cells (AECs), and Proximal 
Tubular Epithelial Cells (PTECs), pre-Inter-alpha-Inhibitor (pre-IaI), Heavy Chain 3- 
bikunin (HC3-bikunin), Chondroitin-4-Sulfate (C4S), hyaluronidase (hyase), Madin-
Darby canine kidney (MDCK) cells, Fetal Bovine Serum (FBS), Bovine Serum Albumin 
(BSA), High Molecular Weight (HMW), Low molecular weight (LMW), N-acetyl-
glucosamine (glcNAc), Amniotic Membrane (AM), Airway Smooth Muscle Cell 
(ASMC), Airway Epithelial Cell (AEC) 
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CHAPTER I 
 
BACKGROUND  
 
I.1. Hyaluronan 
Hyaluronic acid or hyaluronan (HA) is an abundant glycosaminoglycan (GAG) in the 
extracellular matrices (ECMs). GAGs are long, linear and heterogenous polysaccharides, 
which consist of repeating units of disaccharides, with sequences that vary in 
composition of the disaccharide unit, type of linkage and degree of acetylation and 
sulphation. While most GAGs are attached to proteins and are highly sulfated (i.e. 
heparin, heparan sulphate, dermatan sulphate, keratan sulphate and chondroitin sulphate) 
[1], HA is uniquely a much larger, non-sulfated GAG, lacking a core protein. It is a linear 
polymer of repeating disaccharides composed of D-glucuronic acid and D-N- 
acetylglucosamine linked by β (1,4) and β (1,3) glycosidic bonds [2]. HA is not simply 
an inert structural molecule. Rather, it is implicated in many physiological and 
pathological tissue responses such as ovulation and fertilization, embryonic development, 
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tissue fluid homeostasis, inflammation, tissue repair and remodeling, tumor progression 
and metastasis [3]. HA is synthesized by membrane-bound synthases on the inner surface 
of the plasma membrane with the chains being extruded through pore-like structures into 
the ECM. There are three mammalian hyaluronan synthases (HAS1-3). They incorporate 
UDP-sugars (UDP-N-acetyl-D-glucosamine and UDP-D-glucuronate substrates) onto the 
non-reducing end of the growing chain [4,5]. 
 
I.2. TSG-6 Mediated Hyaluronan Modification 
Tumor necrosis factor α (TNFα) induced protein-6 (Tnfaip6), also known as 
TNFa stimulated gene-6 (TSG-6), is a member of the hyaladherin family (HA binding 
proteins). TSG-6 is a 35 kDa secreted protein that is not constitutively expressed in most 
normal adult tissues but is rapidly induced in many different cell types such as 
monocytes, fibroblasts, vascular smooth muscle cells, synoviocytes, chondrocytes, and 
proximal tubular epithelial cells by inflammatory mediators such as interleukin-1 (IL-1) 
and TNFα, lipopolysaccharides and prostaglandin E2 [6,7]. It consists of two domains: 
the N-terminal link (link module) through which it binds to HA and the C-terminal 
(CUB) domain of uncertain function [8]. Besides binding to HA, it can also bind to 
several components of the ECM including chondroitin-4-sulfate (C4S) and inter-α-
inhibitor (IαI). IαI is a proteoglycan produced by liver hepatocytes and released in the 
serum. It is composed of the trypsin inhibitor bikunin with heavy chain 1 (HC1) and 
heavy chain 2 (HC2) that are covalently bound by ester linkages to bikunin via its single 
chondroitin sulfate chain [9]. During inflammation, IαI can ingress into extracellular 
tissue spaces as a consequence of increased vascular permeability where it serves as a 
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heavy chain donor. TSG-6 catalyzes the transfer of HC1 and HC2 from IαI to HA, 
forming the HC-HA complex [Fig. 1] [10,11].  
 
     
 
 
These HC-HA complexes have been identified in synovial fluids from patients with 
rheumatoid arthritis, osteoarthritis [12], and in bronchial secretions of asthmatics [13]. 
Furthermore, the expression of TSG-6 is upregulated in inflamed synovial tissue of 
arthritis [14] and in lungs of asthmatics [15]. The expression of TSG-6 is among the 
genes upregulated > 4 fold in allergen-challenged patients [16] emphasizing the 
important role TSG-6 has during inflammation. HC-HA matrices promote leukocyte 
adhesion to HA matrices as demonstrated in pathological conditions, including, 
rheumatoid arthritis [14],  idiopathic arterial pulmonary hypertension [17,18] and asthma 
[15].  
 
Fig. 1. A Modified Schematic Illustration of the Heavy Chains Transfer to 
Hyaluronan via TSG-6. Inter-α-Inhibitor (IαI) has two HCs (HC1 and HC2) attached 
by ester bonds to N-acetyl-galactosamine residues in the chondroitin sulfate (CS) 
chain on bikunin. TSG-6 removes a HC from IαI to form a HC-TSG-6 intermediate 
and transfers it to form an ester bond to a N-acetyl-glucosamine residue in HA. [15] 
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I.3. Pathological Hyaluronan Matrices 
Adhesive HA structures on their cell surface with coalesced HA strands are referred to as 
HA cables [19]. These modified HA cables have structural information recognized by 
mononuclear leukocytes [20]. Leukocytes can bind to HA cables at 4° C [Fig. 2] and 
rapidly phagocytose the matrix at a physiological temperature of 37° C [19, 20].  
 
 
 
 
 
 
 
Fig. 2. Confocal Image of Leukocytes Bound to HA “Cable” Structures showing 
CD44 “Capping.” Smooth muscle cells (colon) were treated with poly (I:C) to 
induce the synthesis of HA “cable” structures (green) (panel A). U937 monocytic 
leukocytes (CD44, red) bind these structures like “beads on a string” while not 
adhering to HA “coats” found on the cell surface. At permissive temperatures (panel 
B), the monocytic cells relocated, or “capped” CD44 to one pole and internalized HA 
fragments as shown in the enlarged inset. CD44 capped leukocytes were also found 
embedded in an HA matrix from an asthmatic lung biopsy (panel C). Nuclei are shown 
in blue. (Mag. 100X) [19,20]. 
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These leukocyte adhesive HA matrices are seen in lung biopsies from asthmatic patients 
[15] or in response to ER stress at physiological normal levels of glucose [21], and in 
wound healing [22], idiopathic pulmonary hypertension [17,18], airway smooth muscle 
cells in vitro [23, 24] and airway interstitial cells in mouse asthma models [15], 
adipocytes in adipose tissue in a diabetic mice model [25,26] and renal tubular 
endothelial stress [27,28]. The binding of leukocytes to HA cables is essential for its 
removal, which occurs in a CD44-dependent manner [29]. This was demonstrated by 
showing that CD44-/- mice subjected to bleomycin inhalation to induce inflammation 
synthesized and accumulated HA matrix that couldn’t be removed by the influx of 
monocytes and macrophages. Furthermore, the irradiated CD44-/- mice repopulated with 
normal monocytes and macrophages, were able to remove this matrix after the bleomycin 
treatment [30]. 
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CHAPTER II 
 
 
 
MURINE AIRWAY EPITHELIAL CELLS RELEASE THE VAST 
MAJORITY OF THEIR HYALURONAN APICALLY 
 
 
II.1. ABSTRACT 
 
Murine airway epithelial cells behave differently than any other cell type reported so far. 
Besides making leukocyte adhesive HA cables that remain attached to the cell surface 
when stressed, they can also uniquely release HA rafts from their apical surface into their 
extracellular space. This unique release of HA occurs even when the cells are 
unstimulated.  This implies that synthesis of HA rafts may be a normal process of airway 
epithelial biology, though it may be modified during periods of stress and inflammatory 
stimuli. We have developed a physiologically relevant in vitro air-liquid interface (ALI) 
culture model of murine primary airway epithelial cells that closely resembles the in vivo 
airway epithelium. We used this model to characterize these cell-free HA rafts and the 
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mechanism by which this chapter, we show that AECs constitutively release significant 
amounts of HA from their apical surface over the course of their in vitro differentiation in 
comparison to their basal compartment. HA released apically into the extracellular space 
was of a wide range in size with a median of 495 kDa.  
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II.2. INTRODUCTION: 
II.2.1. Airway Epithelium and its Extracellular Matrix 
The primary function of airway epithelium is to function as a physical barrier between the 
external and internal environment. There are three barrier functions: (i) mucociliary 
clearance by trapping and removing inhaled foreign particles from the airways [1],  (ii) 
intercellular apical junctional complexes that regulate epithelial pericellular permeability 
[2], and (iii) secretion of antimicrobial substances such as enzymes, protease inhibitors, 
oxidants, and antimicrobial peptides that kill inhaled pathogens [3,4].  
The airway epithelium sits upon a specialized matrix structure called a basement 
membrane. It is composed of type IV collagen, proteoglycans, laminins and [5]. The 
basement membrane has several important roles in maintaining epithelial integrity: (i) it 
acts as an anchor facilitating adhesion of epithelial cells; (ii) it establishes and maintains 
correct cellular polarity, (iii) it acts as a barrier between the surface epithelium and the 
underlying mesenchymal compartment, and (iv) it provides essential survival signals to 
the epithelium [6].  
II.2.2. Air-Liquid Interface (ALI) Culture Model of Murine Airway Epithelial Cells 
We have developed a physiologically relevant in vitro air-liquid interface (ALI) culture 
model of murine primary airway epithelial cells that closely resembles the in vivo airway 
epithelium. Primary AECs are isolated from murine tracheas by limited proteolytic 
digestion. After a series of purification steps, they are cultured on a native basement 
membrane. This basement membrane on the transwell insert is pre-deposited by Madine- 
Darby Canine Kidney (MDCK) epithelial cells. These steps are summarized as shown in 
[Fig. 3].  
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Fig. 3. A Schematic Illustration of the Main Steps in Murine Airway Epithelial Cell 
Culture. 
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After the AECs reach confluence, the culturing medium is removed (i.e. lifted) from the 
apical chamber, creating an “air-liquid interface” which promotes the differentiation of 
these cells into a mature, pseudostratified, and ciliated airway epithelium (10 – 14) days 
following lift [Fig. 4] [7]. It is also very important at this point to note that these cells are 
grown in serum free medium that lacks the source of IαΙ,  the HC donor, and TSG-6.  
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Fig. 4. Murine Airway Epithelial Cell Differentiation Time Course on Native Basement 
Membrane. Toluidine blue staining of 1 µm epoxy embedded AECs were harvested 0, 3, 5, 7, 10, 
and 14 days after exposure to an air-liquid interface (A-F, respectively). Differentiation progressed 
from squamous (day 0) to cuboidal (day 3) to pseudostratified (days 5-14). Cilia formation was 
apparent by day 5 and reached a plateau between 10 and 14 days. (Mag. 40 X, Magnification bar of 
100 µm). [7] 	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Fig. 5. Three-dimensional Confocal Images of Differentiated Murine Airway Epithelial Cells 
Cultured on a Native Basement Membrane. Cilia are highlighted by β-tubulin IV staining (green), 
and DAPI-stained nuclei are blue. (A) the apical surface of the epithelial cells (Mag. 63X). (B) a 
lateral cross-section of the epithelial cells (magnification is ×63). (C) the apical surface zoomed from 
63X to ~160X, where the gain for the green channel was lowered to highlight individual cilia. All 
magnification bars are 50 µm. [7]	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II.3. MATERIALS AND EXPERIMENTAL PRPCEDURES: 
 
II.3.1. Materials: 
100 mM ammonium acetate, pH 7.0, 400 mM Tris-acetate (T-6791, 500 g, MW 121.1; 
Sigma Aldrich, TRIZMA BASE,), AMAC (2-aminoacridone) Solution (A-6289, 25 mg, 
MW 246.7; Molecular Probes,), sodium cyanoborohydride (15615-9; Sigma Aldrich), 
glacial acetic acid, 10x Proteinase K (Storeroom #155490, 100 mg; Invitrogen,), 
Hyaluronidase, SD (100741-1A; Seikagaku) of a final concentration: 2.5 mU/µl, 
Chondroitinase ABC (100330-1A; Seikagaku) of final concentration: 25 mU/µl, 
Streptomyces hyaluronidase (100740-1; Seikagaku, East Falmouth, MA) of a final 
concentration: 0.5 TRU/mL, 1X TBE (electorphoresis buffer), ammonium persulfate 
(161-0700, 10 g; BioRad), TEMED (N,N,N’N’-Tetra-methylethylenediamine) (161-
0801; BioRad), Select HATM  Hi ladder (HL0503; Hyalose, Oklahoma), Select HATM Lo 
ladder (LL0401; Hyalose, Oklahoma), Mega- HATM ladder (200505; Hyalose, Oklahoma, 
ML), Stains all (1-Ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazolin-2-ylidene)-2-
methylpropenyl]naphtho[1,2-d]thiazolium bromide, 3,3′-Diethyl-9-methyl-4,5,4′,5′-
dibenzothiacarbocyanine) (E9379; Sigma Aldrich). 
 
II.3.2. Mice:  
All mice were maintained in the Biological Resource Unit of the Cleveland Clinic Lerner 
Research Institute in a temperature-controlled facility with an automatic 12 h light-dark 
cycle and were given free access to food and water. All animal protocols were approved 
by the Institutional Animal Care and Use Committee of the Cleveland Clinic. TSG-6-/- 
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mice [8] were a generous gift from Dr. Tibor T. Glant (Rush University Medical Center, 
Chicago, IL), and (4-6)-week-old female TSG-6 -/- mice were used. Wild-type controls 
on a BALB/c background were purchased from Jackson laboratories and used for 
preparing airway epithelial cell cultures.  
 
II.3.3. MDCK basement membrane: 
Basement membranes on the transwells were generated by applying Madin-Darby canine 
kidney (MDCK) cells to the surface of the porous membranes of 12-well tissue culture 
inserts (353180; BD Falcon). After reaching confluence, the MDCK cells were removed 
by detergent lysis using PBS with 0.5% IGEPAL® CA-630 (I8896; Sigma) leaving 
behind a native basement membrane on the transwell surfaces.  The basement membranes 
on the inserts were washed three times to ensure complete removal of the cellular debris. 
This method is similar to our previous method for basement membrane formation, with 
the exception that the basement membrane is not synthesized on a collagen matrix [7]. 
We found that the absence of the performed collagen layer did not hinder the AEC 
adhesion and that the AECs grew more uniformly in the absence of collagen layer.  
 
II.3.4.  Primary Cell Culture: 
After the mice were sacrificed using either pentobarbital or isofluorane, the tracheas were 
excised from the mice and placed in Ham's F-12 nutrient medium with 50 units/ml 
penicillin, 50 µg/ml streptomycin, and maintained at 4° C on ice. Under a dissecting 
microscope, the esophagus and surrounding connective tissue were removed. The 
tracheas were cut longitudinally with a scalpel to expose the lumen and transferred to 5 
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ml of 0.15% pronase (10165921001; Roche Applied Science) in Ham's F-12 nutrient 
medium with 50 units/ml penicillin and 50 µg/ml streptomycin for an overnight 
incubation at 4° C in a 15-ml centrifuge tube. The next day, fetal bovine serum (FBS) 
was added to the tracheas (final concentration 10%) to inhibit further protease 
degradation. The medium, containing the released epithelial cells, was transferred to a 
50-ml centrifuge tube. Washing medium (5 ml), containing Ham's F-12 nutrient medium 
with 50 units/ml penicillin, 50 µg/ml streptomycin, and 10% FBS, was added to the 
tracheas. The 15-ml centrifuge tube, containing the tracheas, was inverted several times 
to dislodge remaining epithelial cells. The supernatant was pooled with the original 
isolate, and the washing step was repeated twice, pooling all supernatants. The pooled 
epithelial supernatants were centrifuged at 300 × g for 10 min. The pellet was 
resuspended in 2 ml of Ham's F-12 nutrient medium with 50 units/ml penicillin, 50 µg/ml 
streptomycin, 10 mg/ml bovine serum albumin (BSA) (BP-1605-100; Fisher), and 
pancreatic DNase I (0.5 mg/ml) (DN-25; Sigma), and was incubated for 5 min on ice 
before it was centrifuged at 300 × g for 5 min. The pellet was resuspended in 12 ml of 
DMEM/F-12 with 100 units/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml 
amphotericin B, 20 mM L-glutamine, and 10% FBS and transferred to a 100-cm2 Petri 
dish and incubated at 37° C, 5% CO2, and 100% humidity for 3 h to allow for the 
attachment of any contaminant smooth muscle cells or fibroblasts onto the dish. 
Afterwards, the culturing medium, containing the non-adherent epithelial cells, was 
transferred to a 10-ml tube. The adherent cells were washed once with 5 ml of medium to 
remove remaining non-adherent epithelial cells and pooled with the first isolate. The 
purified epithelial cells were centrifuged at 300 × g for 10 min. The pellet was re-
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suspended at 100,000 cells/ml in DMEM/F-12 medium containing 100 units/ml 
penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B, 20 mM L-glutamine, 5 
mM glucose (physiological levels), 5% FBS, 10 µg/ml insulin (I-6634; Sigma), 5 µg/ml 
transferrin (T-1147; Sigma), 0.1 µg/ml cholera toxin (C-8052; Sigma), 25 ng/ml 
epidermal growth factor (354001; BD Biosciences), 30 µg/ml bovine pituitary extract (P-
1476; Sigma), and 80 nM retinoic acid (R-2625; Sigma). The cells were seeded onto the 
basement membrane-covered tissue culture inserts at 50,000 cells/well of a 12-well plate. 
AECs were cultured with medium replacement every other day.  After the AECs reached 
confluence, which is normally within 6-7 days from the day they were seeded on 
transwell inserts, the culturing medium is removed (i.e. lifted) from the apical chamber. 
This lift promotes the differentiation of these cells into a mature, pseudostratified and 
ciliated airway epithelium by day 10 after lift.  
II.3.5.  Immunohistochemistry 
Paraffin embedded sections of lung tissues were previously fixed overnight in 10% 
formalin. The sections were rehydrated in PBS for 30 min and then blocked with 1% 
BSA in PBS. HA was labeled with a HA biotinylated binding protein (HABP) (5 µg/mL; 
385911; EMD Chemicals, Gibbstown, NJ) in blocking solution, and then with 
streptavidin conjugated to Alexa Fluor® 488 (1:500, product S11223; Invitrogen, 
Carlsbad, CA). These slides were simultaneously incubated with anti-KDEL (PA1-013; 
Affinity Bioreagents, Golden, CO) conjugates with Alexa Fluor® 594 secondary 
antibody (1:500, product A21203, Invitrogen, Carlsbad, CA). Vectashield mounting 
medium with DAPI (H-1200; Vector Laboratories, Burlingame, CA) was applied to the 
apical surface of the samples followed by coverslip application before visualizing using 
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fluorescent microscopy. 
 
II.3.6. Apical Washes Collection: 
After the culturing medium is removed apically on day 10 of lift, the AECs are being 
cultured on an air-liquid interface, and the apical surfaces are gently washed every other 
day with 200 µL of phosphate buffered saline (PBS) per insert of a 12-well plate. Apical 
washes were pooled and frozen at -80° C until the time of use. 
II.3.7. Fluorophore-Assisted - Carbohydrate Electrophoresis (FACE)  
HA contents in the apical washes and basal media were measured by FACE as previously 
described [9].	  This technique was developed in our laboratory and has many advantages 
over other methods of HA analysis since it can be used to quantify picomolar amounts of 
HA from multiple samples using common vertical gel electrophoresis equipment.  
Briefly, 10X Proteinase K was added to the apical washes or basal conditioned media and 
mixed to give a final concentration of 1X PK then incubated at 37° C overnight. 4 
volumes of pre-chilled (–20° C) 200 proof ethanol was added to each sample, which were 
then incubated at – 20° C overnight. Next day, samples were centrifuged at 14,000 g for 
10 minutes at RT. Supernatants were discarded, and the pellets, which contained the 
glycosaminoglycans, were washed by adding 4 volumes of pre-chilled (–20° C) 75% 
EtOH followed by a short vortex/spin. Samples were then centrifuged at 14,000 g for 10 
minutes as before. Washes were discarded as before, with the residual ethanol removed 
with a pipet. The pellets were dried at RT for 20 minutes. 35 µl 100 mM ammonium 
acetate was added to each sample followed by a vortex/spin, and then incubated at RT for 
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20 minutes followed by a vortex/spin. The PK was heat inactivated by incubating the 
samples at 100° C for 5 min, which were then chilled on ice for 5 min. 1 µl of 
chondroitinase ABC and hyaluronidase SD was added to each 35 µl sample to digest the 
hyaluronan and chondroitin sulfate followed by a vortex/spin, and then incubated at 37° 
C overnight (at least 18 hrs). 160 µl of pre-chilled (–20° C) 200 proof ethanol was added 
to each sample followed by a vortex/spin, and then incubated overnight at –20° C. 
Samples were centrifuged at 14,000 g for 10 minutes at RT. Supernatants were saved in a 
separate 1.5 ml tube (Note: hyaluronan and chondroitin sulfate disaccharides are now in 
the supernatant; heparan sulfate, nucleic acids and other carbohydrates are in the 
pellet). The pellets were then washed with 160 µl of pre- chilled (–20° C) 75% ethanol 
and centrifuged as before. Washes were pooled with the previous supernatants for each 
sample. Pooled supernatants of each sample were lyophilized (using a “Speed-Vac” or 
equivalent), and 2.5 µl of the AMAC solution was added to each sample and incubated at 
37° C for 18 hrs in the dark. The samples were run on a gel prepared by mixing 5 mL of 
(500 mL 40% acrylamide (37.5:1) (161-0148; BioRad), 100 ml Tris-Acetate (400 mM, 
pH 7.0), 370 ml distilled water and 25 ml of glycerol) with 25 µl ammonium persulfate 
(10%) and 5 µl TEMED. The run of the gel was at 500 V constant voltage for 55 minutes 
using the BioRad Mini- PROTEAN® Tetra Cell.  
A detailed protocol is found on our Program of Excellence in Glycosciences at Cleveland 
Clinic webpage:	  	  
http://pegnac.sdsc.edu/cleveland-clinic/files/PEGNAC_FACE_Prot_GAGsv1_1.pdf 
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Images of the gels were taken using myECL Imager (Thermo Scientific), and the band 
intensities were quantified using ImageJ software that can be downloaded using the link: 
http://imagej.nih.gov/ij/ 
 
II.3.8. HA sizing 
10X Proteinase K was added to pooled apical washes, from 12 transwell inserts of AECs 
every other day during the time course of their differentiation, and mixed to give a final 
concentration of 1X PK, and then incubated at 37° overnight. 4 volumes of ice cold 200 
proof ethanol were added to the samples followed by a Vortex/Spin and then incubated 
overnight at -20o C. The samples were centrifuged at 13,200 g for 10 min, and the 
supernatants were decanted.  The pellets were washed with 1 ml ice cold 75% ethanol 
and centrifuged as before, and then air dried for 20 minutes before re-suspending them in 
0.1 ml of 100 mM ammonium acetate (pH 7.0). The proteinase K in the samples was heat 
inactivated on a boiling water bath for 10 minutes, and then spun down. 3 µl of DNAse 
(2224, 2 U/ul; Ambion) and 3 µl of RNAse A (109169, 1.28 mg/ml; Roche) were added 
to each sample and incubated overnight at 37o C. The enzymes were heat inactivated on a 
boiling water bath for 5 min and then spun. 400 µl cold 200 proof ethanol was added to 
each sample and incubated overnight at -20o C. Samples were centrifuged at 13,200 g for 
10 min, and then washed with 1 ml cold 75% ethanol and centrifuged as before. A p200 
tip was used to remove any residual ethanol, and the pellet air-dried. Pellets were re-
suspended in 20 µl 100 mM ammonium acetate (pH 7.0) and transferred to a 200 µl PCR 
tube. 1 µl of each sample was transferred to a separate tube and saved for subsequent 
FACE analysis. 1 µl sialidase (N8271-0.2UN; Sigma) was added, and each sample was 
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divided in half by transferring 9.5 µl to another tube to which 1 µl Streptomyces 
hyaluronidase (100740-1, 0.2 TRU/µl stock; Seikagaku) was added and incubated 
overnight at 37oC. The other half was incubated without the enzyme. The enzymes were 
heat inactivated on a boiling water bath for 5 minutes and then spun down.  The samples 
were lyophilized by “Speed-Vac” and re-suspended in 10 µl of 10 M formamide (F-476, 
10 M; Sigma-Aldrich,), and then incubated overnight at 4o C. Samples are run on a 1% 
agarose gel (SeaKem HGT Agarose, 50041; Cambrex) in 1x TAE that is pre-run for 6 
hours at 80 V (constant voltage) to remove impurities that stain strongly with Stains-All. 
2 µl tracking dye (0.2% bromophenol blue in 10 M formamide) was added to the 
samples. The entire sample (now at 12 µl) was loaded to a well. The gels were run at 100 
V (constant voltage) until the tracking dye has migrated about 75% the length of the gel 
(1-1.5 hr). The gels are then transferred into a dish with 30% ethanol to equilibrate the gel 
into ethanol, which prevents the formation of Stains-All precipitates, and then rocked for 
1 hour.  The ethanol was decanted and replaced with Stains-All solution (E-9379; Sigma) 
for overnight incubation. The gel was totally covered to prevent light from degrading the 
dye. The stain was removed and replaced with water followed by shaking for 1 hour. The 
gel was briefly (less than 1 hour) exposed to light to decrease background as needed.  The 
gel was scanned on a standard color scanner.  
 
II.3.9. PCR Analyses  
RNA was isolated using the RNAeasy kit (74104; Qiagen), and cDNA was prepared 
using Superscript @ First-Strand Synthesis System (11904-018; Invitrogen).  Primers of 
HAS 1-3 used are listed in [Table 1] as previously reported in Cheng et al [10]. The PCR 
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conditions were 1 cycle at 94° C for 3 min, 40 cycles of 95° C for 30 sec, 55° C for 45 
sec, 72° C for 1 min, followed by 1 cycle of 72° C for 1 min. These conditions were used 
for all primers. PCR products were run on 3% ethidium bromide gels (E1510; Sigma) and 
1% agarose gels (SeaKem® HGT Agarose, 50041; Lonza). 
 
 
 
 
 
Name of Primers Primer Sequence Expected PCR product 
!-actin  5’-GGTCATCACTATTGGCAACG-3’  
5’-ACGGATGTCAACGTCACACT-3’  
133 bp 
HAS1 5’!GGTGGTTACCGTGTCCAAGTAT-’3 
5’-GAAGGTAAACTGAGTCCCCAGA-3’   
120 bp 
HAS2 5’-GGTCCAAGTGCCTTACTGAAAC-3’  
5’-TGTACAGCCACTCTCGGAAGTA-3’  
96 bp 
HAS3 5’- AGACCGAGCTAGCCTTCCTAGT-3’  
5’-TAATGGCCAGATACAGCATGAG- 3’  
84 bp 
Table 1. The Sequences of the Polymerase Chain Reaction (PCR) Amplification Primers 
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II.3.10.  Statistical Analysis 
Data are presented as the mean ± SEM; n is indicated in figure legends in representative 
experiments.   
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II.4. RESULTS AND DISCUSSION 
 
II.4.1. HA rafts on apical surfaces of murine airway epithelial cells (AECs) in vivo and 
in vitro.  
HA is located on the apical surfaces (white arrows) of murine AECs as distinct clumps, 
or HA rafts (green), that can be seen both in vivo on a normal WT epithelium [Fig. 6A] 
and on an air/liquid day 10 AEC culture in vitro [Fig. 6B]. Furthermore, the air/liquid 
AEC culture model closely resembles its in vivo counterpart, as previously shown [7] in 
terms of its pseudo-stratification, cellular morphology, presence of cilia, and KDEL (a 
Endoplasmic Reticulum marker) distribution. Thus, it represents a compatible model to 
study the HA rafts that murine AECs make.  
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 5 µm 
Fig. 6. HA Rafts are Loosely attached to the Apical Surface of Murine Airway Epithelia in 
vivo and on AEC Lift Cultures in vitro. Paraffin embedded sections of a murine airway 
epithelium (A) in vivo, and a 10-day differentiated air/liquid AEC culture (B) in vitro, were 
stained for HA with a fluorescent conjugate of a biotinylated HA binding protein (green). 
Nuclei were stained with DAPI (blue) and for endoplasmic reticulum (ER) (red) with an 
antibody against KDEL.  The arrows indicate the apical HA rafts.  HA is also apparent in the 
basal areas with most of it in the underlying connective tissue in vivo.  Images are from a 
zoomed in micrograph (Mag. 63X , magnification bar of 5 µm).  	  
Lauer	  M.	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II.4.2. Murine AECs release the majority of HA from their apical surface.  
 
The apical surfaces of air/liquid AEC cultures were gently washed during their course of 
differentiation over 10 days and analyzed for HA [Fig. 7].  HA in the basal media was 
also measured for comparison.  The results indicate that the HA shown to be on the 
surface [Fig. 6B] is loosely attached, and that only small amounts are present in the basal 
medium.  This implies that the synthesis of this loosely attached HA on the apical surface 
of AECs, which also appears to be present in vivo [Fig. 6A], may be a normal process of 
airway epithelial biology, though it may be modified during periods of stress and 
inflammatory stimuli.  
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Fig.7. Murine AECs release Most of their HA from their Apical Surface. The bar graph 
shows the amounts of HA determined by FACE in the apical washes (black bars), and basal 
media (grey bars) collected during the differentiation phase of AEC cultures (N=6). The values in 
the apical washes are statistically greater p<0.01 than those in the basal media from 2 through 10 
days of differentiation with apical washes taken every 2 days.  
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II.4.3. Murine AECs release a wide range of HA sizes from their apical surface.  
 
The size of HA varies between cell/tissue type and can have a profound effect on the 
function of HA [11].  HA fragments generated by multiple mechanisms throughout the 
course of inflammatory pathologies, elicit cellular responses distinct from intact HA [12]. 
Typically, the full-length polymer has a very high molecular mass, ranging from 105 to 
107 Da. The high molecular mass HA serves as a space filler, osmotic buffer, and 
viscoelastic structure [13]. Under certain physiological and pathological conditions, HA 
oligosac- charides exhibit quite different biological activities from the polymers, 
including induction of angiogenesis [14] and cell proliferation [15]. AECs uniquely 
release the vast majority of their HA from the apical surface in comparison to what is 
released basally during their differentiation time course. To determine the size of HA in 
the HA raft, we analyzed the HA in the apical washes of murine WT AECs collected 
every other day during their differentiation time. The size of HA of the HA raft is 
variable and ranges between very high molecular weight HA to as low as 27 kDa with a 
median of 495 kDa as shown in [Fig. 8]. This implies that AECs dynamically metabolize 
the HA, synthesizing very high molecular weight (HMW) HA ranging between (1520-
6100 kDa) and breaking it down by hyaluronidases into smaller fragments.  
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Fig. 8. Hyaluronan Size Analysis by Agarose Profiling. The size of hyaluronan of the 
HA raft is analyzed on a 1% agarose gel stained with Stains all. The agarose profiling 
shows both high and low molecular weights (Hi and Lo HA) of hyaluronan standards. 
Mega HA standards range between (1520 – 6100) kDa. The left lane shows a ladder of 
HA MW standards. The Streptomyces hyaluronidase (hyase) specifically breaks down 
the hyalronan into disaccharide units and was used in this experiment to demonstrate 
that the detected smears on the gel are of hyaluronan composition.  
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II.4.4. Murine AECs express HAS1-3 that are involved in the synthesis of HA rafts.  
 
HA is synthesized by membrane-bound synthases on the inner surface of the plasma 
membrane with the chains being extruded through pore-like structures into the ECM. 
There are three mammalian hyaluronan synthases (HAS1-3) [16,17]. HAS2 is the most 
crucial enzyme in HA synthesis since mice lacking the ability to express HAS2 die at 
mid-gestation[18] while HAS1 or HAS3 knock-out mice show no effect on fetal 
development [19]. 
AECs can express all three HAS isoforms especially HAS2 and HAS3 that are involved 
in the HA synthesis as shown is [Fig. 9]. This HA could be part of the ECM of the AECs 
but is mostly released into the extracellular space as HA rafts as shown in [Fig. 7].  
 
  !?actin    HAS1     HAS2     HAS3"
 
Fig. 9. Relative Gene Expression of Hyaluronan Synthases by AECs. Hyaluronan 
Synthases (HAS) 1-3 expression of a 10 day murine AECs is shown by the ethidium 
bromide stained PCR product of HAS1-3 separated on a 1% agarose gel. (N=3).  
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CHAPTER III 
 
 
 
MURINE AIRWAY EPITHELIAL CELLS MAKE LEUKOCYTE-ADHESIVE 
HYALURONAN RAFTS LOCATED ON THEIR APICAL SURFACE 
 
 
III.1. ABSTRACT 
 
For the past decade, a variety of cell types were shown to synthesize leukocyte- adhesive 
HA structures on their cell surface, which resemble braided rope made of individual HA 
strands known as HA cables, in response to a variety of inflammatory stimuli. In all cell 
types studied to date, the leukocyte-adhesive HA cables synthesized by these cells remain 
attached to the cell surface. However, while AECs also form HA cables on their cell 
surface in response to a variety of inflammatory stimuli, they also actively release a 
majority of their leukocyte-adhesive HA structures into the extracellular space from their 
apical surface even when they are not stimulated. In this chapter, we demonstrate that 
AECs can make leukocyte adhesive HA rafts that are loosely attached to the cell surface 
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because of the heavy chain (HC) transfer onto the HA raft that is mediated by TSG-6. 
These structures are not only found in our in vitro culture model but also in vivo. 
Leukocyte-,adhesive HA rafts were found in the bronchoalveolar lavage (BAL) of naïve 
wild type mice, and were observed on their apical ciliated surfaces. HA rafts were also 
found in the BAL of a TSG-6 null mouse, but the HC transfer onto the HA was absent.  
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III.2. INTRODUCTION  
 
 
HA “cables” were first identified as HA rope-like structures that were attached to the 
surfaces of colon smooth muscle cells treated with poly (I:C), a viral mimic, and that 
promote leukocyte adhesion [1]. HA “cables” formed at the cell surface of a variety of 
cells in response to a variety of inflammatory stimuli and function as a ligand for 
inflammatory cells. We have previously found that transfer of HCs during the formation 
of these HA “cable” structures on airway smooth muscle cells (ASMCs), upon treatment 
with poly (I:C),  stabilizes them, resulting in a more pronounced cable formation which 
promotes greater leukocyte adhesion [Fig. 10] [2]. The addition of TSG-6 catalyzed the 
transfer of HCs from IaI present in the serum in the medium onto the HA that is being 
induced by poly (I:C) treatment. Leukocytes adhesion to these cables is in a HC-
independent manner as shown in [Fig. 10B and 11], but substitution of these cable 
structures with HCs significantly promoted leukocyte adhesion as shown in [Fig. 10C].  
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Fig. 10. The HC-HA Complex promotes Leukocyte Adhesion to HA Cables. 
Confocal images showing mononuclear U937 leukocytes (red with CD44 staining) bound 
to HA cables in ASMCs (green, with hyaluronan binding protein staining), induced by 
poly (I:C), or a combination of poly (I:C) and TSG-6 compared to untreated controls 
(NT). Nuclei are blue (DAPI staining). The addition of TSG-6 significantly enhanced 
leukocyte adhesion to HA cable structures via the formation of the HC-HA complex [2]. 
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Fig. 11. Addition of HCs to HA Cables via Recombinant TSG-6. HA “cables” 
produced by ASMCs in response to poly (I:C) lack the HC modification. The addition of 
recombinant TSG-6 was used to artificially add HCs to HA “cables” to form the HC-HA 
complex. (A) Confocal images of ASMCs probed with an antibody against HCs (red) 
with nuclei in blue (Mag. 63x). (B) Western blot of Strepotmyces hyaluronidase extracts 
from these cables, thereby releasing the HCs (green) into the extract (N = 3) [2].  
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AECs produce leukocyte adhesive HA “cables” like other cell types in response to 
inflammatory stimuli such as tunicamycin, which results in an endoplasmic reticulum 
(ER)-stress [Fig. 12] [3]. Interestingly, we report for the first time the release of 
leukocyte- adhesive HA rafts from the apical surface of AECs that occurs in the absence 
of inflammatory stimuli. This implies that the synthesis of HA rafts is a part of normal 
respiratory secretions by AECs.  
 
      
B.  
 
Fig. 12. U937 Monocytic Cells bind to Hyaluronan on the Apical Surface of 
Differentiated Murine Airway Epithelial Cells treated with Tunicamycin. CM-DiI-
labeled U937 cells (red) were applied to the apical surface of epithelial cells treated 
without (A) or with tunicamycin (B). Hyaluronan (green) was labeled with fluorescence-
tagged streptavidin on a biotinylated hyaluronan binding protein. (Mag. 40X, 
magnification bar of 100 µm) [3]. 
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III.3. MATERIALS AND EXPERIMENTAL PROCEDURES 
 
 
 
III.3.1. Mice 
As described in section II.3.2. [4].  
 
III.3.2. Apical Washes Collection 
 
Apical washes were collected by gently washing the apical surface of differentiated AEC 
cultures of day 10 after lift, removal of apical media, with 500 µL of phosphate buffered 
saline (PBS). 
 
III.3.3. Leukocyte Binding to Apical Washes Collected from AEC cultures  
 
U937 cells, a human monocytic leukocyte cell line, suspended in RPMI medium with 100 
units/ml penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B and 20 mM L-
glutamine were used for this binding assay. Around 50,000 U937 cells were incubated 
with 500 µL apical wash, which was collected from a day 10 AEC culture, for an hour at 
4° C then transferred to a glass slide via cytospin and left to air dry completely before the 
processing for immunohistochemistry [Fig. 13]. 
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500 µL apical wash of a  differentiated 
airway epithelial cells ( day 10) 
+!
2. transfer onto a glass slide 
via cytospin 
        U937 cells ( human leukocyte cell line) 
 
1.  incubated with the apical wash for an hour at 4° C  
3. leave to air dry completely 
 
 
 
 
 
 
 
 
 
 
Fig. 13. A Schematic Illustration of the Main Steps in U937 Cells Binding Assay to 
the HA rafts in vitro.  	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III.3.4. Bronchoalveolar Lavage (BAL) Collection 
 
Mice were euthanized by using isofluorane or pentobarbitol. BALs were obtained by 
cannulating the trachea with a 24 gauge-feeding needle and lavaging the lungs with 600 
µL of PBS. The typical BAL fluid returned was 400-500 µL. A 100 µL aliquot of the 
collected BAL was transferred to a glass slide via cytospin and left to air dry completely 
before processing for immunohistochemistry.  
 
 
III.3.5. Immunohistochemistry 
 
 
Aliquots of BAL or apical washes from day 10 AEC cultures were transferred to a glass 
slide via cytopsins and were air dried completely.  Samples were then fixed with 100% 
methanol at -20° C for 10 min and air dried for 1 h. Methanol fixed cytospins of BAL and 
apical washes of AECs were rehydrated in PBS for 30 min and then blocked with 1% 
BSA in PBS. HA was labeled with a HA biotinylated binding protein (HABP) (5 µg/mL; 
385911; EMD Chemicals, Gibbstown, NJ) in blocking solution, and then with 
streptavidin conjugated to Alexa Fluor® 488 (1:500, product S11223; Invitrogen, 
Carlsbad, CA). These slides were simultaneously incubated with a cocktail of antibodies 
to HC1, HC2 and HC3, using Alexa Fluor® 594 donkey anti-mouse secondary (1:200; 
product A11058; Invitrogen) or anti-CD44 (1:250; product C7923, Sigma-Aldrich, St. 
Louis, MO) or anti-KDEL (PA1-013; Affinity Bioreagents, Golden, CO). Vectashield 
mounting medium with DAPI (H-1200; Vector Laboratories, Burlingame, CA) was 
applied to the apical surface of the samples followed by coverslip application before 
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visualizing using fluorescent microscopy.  
 
III.3.6. Western Blot Analysis 
 
 
Samples were electrophoresed on 10% SDS–PAGE and transferred onto Immobilon-P 
membranes (Millipore). All blots were blocked for 1 h with 5% milk (Blotting Grade 
Blocker, 170-6404; BioRad) and probed overnight at 4° C with antibodies against HC1 
(SC-33944; Santa Cruz Biotechnology), HC2 (SC-21978; Santa Cruz Biotechnology), 
HC3 (SC- 21979; Santa Cruz Biotechnology), and IαI (A0301; Dako Cytomation, 
Denmark). Blots were washed with 1X Tris Buffered Saline (TBS) with TWEEN®20 
(0777-2 L; AMRESCO) 3 times for 7 minutes each time. Blots were then incubated with 
donkey anti-goat IgG-HRP (SC-2020; Santa Cruz Biotechnology) as secondary antibody 
for 1 h at room temperature then washed again for three times for 7 minutes each time. 
TSG-6 was assessed using a biotinylated anti-mouse TSG-6 antibody (BAF2326; R&D 
systems, Inc.) followed by the treatment with streptavidin-horse radish peroxidase (HRP) 
(P0397; Dako Cytomation) for 1 h at room temperature. Recombinant mouse TSG-6 
(2326-TS; R&D systems, Inc.) was used as a positive control for the TSG-6 antibody. All 
blots were developed using the ECL Prime Western Blotting Detection Reagent 
(RPN2232, Amersham) and detected protein band intensities were measured using 
ImageJ software (http://imagej.nih.gov/ij/). Protein standards (Fermentas Page Ruler 
Prestained Protein Ladder, SM0671; Thermo Pierce) were used with each gel that was 
run.  
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III.3.7. Hyaluronidase Extraction of HCs from the HC-HA Complex  
 HCs were determined in bronchoalveolar lavage (BAL) samples and in apical washes of 
10 day air/liquid interface cultures of primary differentiated AECs by treatment with or 
without Streptomyces hyaluronidase (0.5 TRU/mL; 100740-1; Seikagaku, East Falmouth, 
MA) overnight at 37° C. The supernatants were then analyzed by Western blotting.  
 
III.3.8 Statistical Analysis 
 
Data are presented as the mean ± SEM; n is indicated in figure legends in representative 
experiments.   
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III.4. RESULTS AND DISCUSSION 
 
 
III.4.1 Murine AEC cultures release leukocyte adhesive HA rafts from their apical 
surface. 
 HA cables are formed at the cell surface of a variety of cells including AECs [5] during 
inflammatory processes. These structures are known to function as a ligand for 
inflammatory cells [1]. However, the majority of the apical HA produced by AECs can 
be released into the extracellular space as HA rafts. To investigate whether these rafts are 
also leukocyte adhesive, we incubated the apical washes of 10 day AEC cultures with a 
human cell line of monocytic U937 cells for an hour at 4° C. Subsequently, an aliquot 
was transferred to a slide via cytospin, and stained for CD44, a HA receptor. Multiple 
clusters of U937 cells were embedded in the HA rafts as shown in [Figure 14A-C].  
Murine AECs behave differently than any other cell type reported so far. Besides making 
leukocyte adhesive HA cables that remain attached to the cell surface in response to a 
variety of inflammatory stimuli, they also actively release a majority of their HA matrices 
into the extracellular space from their apical surface. These matrices do not resemble the 
rope-like HA cables, but occur in distinct sheets or rafts of HA that are leukocyte-
adhesive. 
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!
! D. Secondary antibodies only   
Fig. 14. Leukocyte-Adhesive HA Rafts in vitro. (A-C) Monocytic U937 cells were 
suspended in the apical wash from a 10 day AEC culture for 1 h at 4o C and subsequently 
cytospinned onto a slide. HA was stained with a fluorescent conjugate of biotinylated HA 
binding protein (green). U937 cells were probed with antibodies against CD44 (red). This 
fluorescent micrograph shows multiple clusters of U937 cells embedded in HA rafts 
(Mag. 20X). (N=3).  
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Furthermore, similar adhesion of U937 cells was observed when they were added to the 
apical surface of an AEC culture [Fig. 15]. This indicates that the HA rafts released by 
the AECs are also leukocyte-adhesive similar to the HA cables that are known to form in 
other pathologies. However, in this case, they are not being formed in response to a 
pathological stimulus.  
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 10 µm!g 
h 
 
 
Fig. 15. Murine AECs release Leukocyte-Adhesive HA Rafts from their Apical  
Surface. The micrograph of a section of non-stimulated 10 day AEC culture (Mag. 63X, 
magnification bar of 10 µm) shows an example of U937 monocytes (g) binding to the 
loosely attached HA raft (h).  
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B. CD44 
50 µm 
D. Overlay + DAPI C. HA 
A. DAPI 
 
Fig. 16. U937 Cells don’t cluster in the Absence of HA Rafts. (A-D) U937 cells in 
RPMI medium were transferred to a glass slide after one hour incubation at 4o C without 
the addition of day 10 AEC culture’s apical wash that contains the HA rafts. Absence of 
HA was shown by lack of staining with a fluorescent conjugate of biotinylated HA 
binding protein (green). U937 cells were probed with antibodies against CD44 (red). This 
fluorescent micrograph shows that U937 cells don’t cluster, as in [Fig. 14], in the absence 
of HA rafts due to the centrifugal force resulting when the cells are transferred to the 
glass slide via cytospin. (Mag. 20X, magnification bar 50 µm). (N=3). 
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III.4.2. HA rafts contain HC-HA complexes. 
 One possible explanation for the HA adhesiveness to leukocytes is due to a HA 
modification that often occurs during inflammations, namely the transfer of HCs from IαI 
to form HC-HA complexes, which is mediated by TSG-6 [6,7]. Apical washes of 10 day 
AEC cultures were collected at the indicated times (2-48 h) after replacing the medium 
on day 10. They were then treated with Streptomyces hyaluronidase (specific for HA 
digestion into disaccharides) and analyzed for HCs by Western blots [Fig. 17A]. The 
accumulation of HCs at ~85 kDa over the time course is apparent. This band was not 
present in the absence of the hyaluronidase digestion as shown in the analysis of a 12 day 
apical wash [Fig. 17C]. This provides evidence that monocyte binding is due to a large 
extent by the presence of HCs [8,9], and that the HA rafts contain HC-HA complexes. 
Furthermore, TSG-6 was also present in the apical washes and absent in apical washes 
from TSG-6 null AECs [Fig. 17B].  The absence of HC-HA in the TSG-6 null cultures is 
also apparent [Fig. 17A]. 
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Fig. 17. Murine AECs make HA rafts that contain HC-HA complexes. Western blots 
of apical washes of unstimulated AECs were collected at 2, 4, 8, 24 and 48 h after day 10 
of their differentiation and treated with Streptomyces hyaluronidase (S. hyase) and then 
(A) probed with a cocktail of HC1, 2 and 3 antibodies, and (B) re-probed with TSG-6 
antibody. Absence of HC transfer and TSG-6 from a parallel experiment with AECs from 
TSG-6 null mice is apparent in (A) and (B) consecutively. (C) Western blot of an apical 
wash collected on day 10 of differentiation, 48 h after the previous apical wash, treated 
without or with S. hyase. This blot was probed with an antibody against IαI.  
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III.4.3. HA rafts in murine bronchoalveolar lavage (BAL) require TSG-6 for HC 
transfer onto HA. To determine whether HA rafts are HC-HA complexes released by the 
airway epithelium in vivo, we analyzed BAL samples from a naïve WT mouse and found 
clusters of HA that are monocyte adhesive similar to the HA rafts that AECs make in 
vitro as shown in [Fig. 18A-C]. Furthermore, these HA rafts lacked HCs in the absence 
of TSG-6 as shown in the BAL collected from a TSG-6 null mouse [Fig. 18D-F], which 
is consistent with the fact that HC transfer onto HA requires TSG-6.  Moreover, the size 
of the HA raft in the TSG-6 null BAL fluid was much smaller, suggesting that the lack of 
TSG-6 may have an effect on the synthesis or aggregation of HA. This is consistent with 
the significant decrease of pulmonary HA concentration measured in the BAL and lung 
tissues of TSG-6 null mice subjected to the ova asthma model [10].  Furthermore, 
digesting the BAL collected from naïve WT mouse with S. hyase resulted in the release 
of significantly more HCs into the gel that were detected on Western blots [Fig. 19A,B] 
while HC bands were nearly absent (<10% of control) in BAL from a TSG-6 null mouse. 
This demonstrates the role of TSG-6 in mediating HC transfer onto HA in rafts located 
on the apical surface.  Moreover, we have previously shown that TSG-6 can transfer all 
of the HCs from serum-derived HC-bikunin to HA1000K in vitro at early time points 
while TSG-6 released free HCs from HA1000K at later time points to a lesser extent [11]. 
This may explain the observation of free HCs in the presence of TSG-6 when WT BAL 
was not treated with S. hyase.   
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Fig. 18.  HA Rafts in Murine BAL require TSG-6 for HC Transfer onto HA.   HA 
rafts are present in BAL from naïve wild type (WT) (A-C) and from TSG-6 null mice (D-
F). HA was stained with a fluorescent conjugate of biotinylated HA binding protein 
(green), and the presence (B) and absence (E) of the HC-HA complex was shown by 
staining with a cocktail of HC1, 2 and 3 antibodies (red). Leukocytes were stained with 
DAPI (blue). (Mag. 20X, magnification bar of 50 µm).  
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Fig. 19. HC-HA Complex is found in BAL of Naïve WT and not in that of TSG-6 
Null Mice. (A) One representative out of 3 Western blots of BAL from naïve WT and 
TSG-6 null mice that were incubated without or with S. hyase. (B) Bar graph 
representation of the HCs released by S. hyase indicates the amount of HC-HA in BAL 
from naïve WT mice, which is absent in the BAL of TSG-6 null mice (N=3).   
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CHAPTER IV 
 
 
 
MURINE AIRWAY EPITHELIAL CELLS CONSTITUIVELY 
SYNTHESIZE THEIR OWN HEAVY CHAIN DONOR AND 
TSG-6 
 
IV.1. ABSTRACT 
 
 
The HC-HA modification involves the transfer of heavy chains from the inter-α-inhibitor 
(IαI) proteoglycan, which has 2 heavy chains (HC1 and HC2) on its chondroitin sulfate 
(CS) chain. The transesterification transfer of HCs from CS to HA is mediated by tumor-
necrosis-factor-induced-gene 6 (TSG-6), which is upregulated in inflammatory reactions. 
IαI, the heavy chain donor, is normally produced by liver hepatocytes and released into 
the plasma. Very few other cell types have been reported to constitutively express their 
own heavy chain donor.  In this study, we show that murine AEC cultures synthesize 
TSG-6 and their own heavy chain donor (pre-IaI) with a single heavy chain 3 (HC3) 
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linked to a bikunin as HC3-bikunin, which are also constitutively expressed by human 
renal proximal tubular epithelial cells. Therefore, AECs synthesize HC3-bikunin to act as 
a HC donor that is involved in the HC transfer mediated by TSG-6 onto the HA forming 
HC3-HA rafts. These HC3-HA rafts that are located on the apical surface of AECs are 
leukocyte adhesive.  Thus, these leukocyte-adhesive HA rafts are now identified as HC3-
HA complexes that could be part of a host defense mechanism filling some important 
gaps in our current understanding of murine airway epithelial biology and secretions.  
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IV.2. INTRODUCTION  
 
IV.2.1. Inter-trypsin-α-Inhibitor (IαI) Family 
In mammals, the bloodstream is a major carrier for many glycoproteins that act as 
protease inhibitors. Inter-α-inhibitor (IαI) and related molecules, collectively referred to 
as the IαI family, are a fascinating group of such plasma protease inhibitors. The 
discovery of an increasing number of such molecules has raised numerous questions 
about their pathophysiological functions [1]. Until recently, the knowledge of the IαI 
family was mostly structure oriented. Indeed, IαI was for many years described as a 
single entity, and a major breakthrough in the late 1980s was the emergence of a set of 
related molecules. At least four heavy chains (HCs) designated HC1, HC2, HC3 and HC4 
[2-4], are involved in the synthesis of IαI family members [Fig. 20] [5,6].  
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2 J. P. Salier and others
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Figure 1 A current view of the IαI family, from genes to glycoproteins
This current view of the biosynthetic pathways in the IαI family is modified from a former proposal [1]. The homologous areas of the human and mouse chromosomes to which a given gene
maps are indicated by the species (HSA, Homo sapiens ; MMU, Mus musculus) and the chromosome band numbers (H4 gene mapping : L. Jean, M. G. Mattei, F. Banine and J. P. Salier, unpublished
work). Symbols read as follows. mRNAs : thin line, non-coding sequence ; black box, open reading frame. Precursor polypeptides : crossed box, signal peptide ; hatched box, α1m; double-hatched
box, bikunin ; black box, N-terminal cleavage product of H precursor ; pink box, mature H chain ; grey box, C-terminal cleavage product of H precursor. Glycoproteins : wavy line, covalent PGP
cross-link. Only the major members of the IαI family are depicted ; for the sake of clarity, their former, usual, acronyms as well as the newly proposed nomenclature (see Table 2) are given.
Table 1 Sizes of the H1 to H4 precursor polypeptides and mature chains
HxP, precursor polypeptide ; Hx, mature chain found in some IαI-related plasma proteins. The
sizes are expressed as the number of amino acid residues, as inferred from the cDNAs and
protein sequences published and/or discussed in [2,3,9,10,11,63,64]. The signal peptides as
defined in [2,3] are not included in the precursor sizes indicated. Note that the order H2P, H1P,
H3P, H4P, as shown, reflects the most closely related polypeptide pairs : H1P and H3P ; H3P
and H4P [2–4]. A possible trimming of a 36-amino-acid propeptide at the N-terminus of
H2P [3,9] is included in the calculations. The H4P polypeptide can undergo some
cleavage steps after its secretion into plasma, eventually resulting in a major 633-amino-acid
peptide (see text and [2]). n.a., not applicable ; n.d., not determined.
No. of amino acids
H2P H2 H1P H1 H3P H3 H4P H4
Human 928 648 882 643 868 630 902 n.a.
Mouse 928 648 881 642 868 628 n.d. n.d.
unknown. The mRNAs of these genes are 2.9–3.3 kb in size
[1,2,6].
The cDNA-deduced H1, H2 and H3 polypeptide sequences,
but not the H4 sequence, are considered to represent precursors
[2,3,9,10] (Table 1). Indeed, these precursors undergo extensive
trimming of their C-terminal ends, with removal of 240–280
amino acid residues (Figure 1; Table 1), as judged from the
sequences of the mature H polypeptides found in the purified
plasma proteins. Furthermore, the H2 precursor displays a
stretch of 36 amino acids located between its signal peptide and
the N-terminus of the mature H2 chain, which suggests a further
trimming of a propeptide at the H2 N-terminus [3,9,11] (Figure
1; Table 1). Based upon the N-terminal amino acid sequences of
the purified H chains [11] and alignment of the cDNA-deduced
sequences, the presence of a similar propeptide in the H1, H3 and
H4 precursors is unlikely, as discussed elsewhere [3].
In addition to the four H genes, another gene, designated the
α1-microglobulin (α1m)￿bikunin precursor (AMBP) gene, is
involved in the synthesis of most IαI family members (Figure 1;
Table 2). The AMBP mRNA encodes a precursor for two
polypeptides, α1m and bikunin. The AMBP gene is comprised of
six α1m-encoding exons and four bikunin-encoding exons
separated by a large (7 kb) intron, suggesting that the modern
AMBP gene resulted from the fusion of two ancestral α1m and
bikunin genes [12]. As homologous AMBP mRNAs have been
cloned in many vertebrates, including human, pig, rodents and
fishes [13–20], this gene fusion event must have taken place prior
to the teleost–tetrapod divergence that occurred some 400million
years ago. The AMBP-gene-encoded polypeptide undergoes a
cleavage step (see below) that releases α1m and bikunin; these
 
 
 
 
Fig. 20. A Curr nt View of the IαI Family, from Genes to Glycoproteins. [5] 
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IαI is an abundant proteoglycan produced by liver hepatocytes and released in the serum. 
It is reported to circulate in serum at concentrations between 150 and 500 µg/mL 
comprising  ~5% of total protease inhibitory activity of plasma, and elevated levels are 
reported in inflammatory pathologies [7,8]. It is normally composed of the trypsin 
inhibitor bikunin with heavy chain 1 (HC1) and heavy chain 2 (HC2) that are covalently 
bound by ester linkages to bikunin via its single chondroitin4-sulfate (C4S). The 
chondroitin sulfate chain is linked through an ester bond between C-terminal aspartate 
and the 6-hydroxyl of an N-acetylgalactosamine. The transesterification transfer of HCs 
from C4S of the IαI to a 6-hydroxyl of an N-acetylglucosamine of HA is mediated by 
TSG-6, a protein secreted by various cells upon stimulation by inflammatory cytokines 
[9-16].  
 
IV.2.2. TNFα Stimulated Gene-6  (TSG-6) 
Tumor Necrosis Factor α (TNFα)-induced protein-6 (Tnfαip6) also known as TNFα-
stimulated gene-6 (TSG-6) is a member of HA binding proteins [17]. It is a 35 kDa 
secreted protein that is involved in both physiological and pathophysiological tissue 
responses. Besides interacting with HA [18-20], this protein also interacts with a broad 
spectrum of GAGs and protein ligands, including C4S [21], heparin [22], IαI [23-24], 
aggregan [25] and pentraxin-3 (PTX3) [26].  TSG-6 is produced by many different cell 
and tissue types in response to a wide variety of stimuli [27]. The expression of TSG-6 is 
induced by a number of factors other than TNF-α including IL-1β, TGF-β, and LPS in a 
highly cell type-dependent manner, and in many cases is coordinated with the synthesis 
of HA. TSG-6 expression has been observed in physiological and pathological contexts 
	  	  	   67	  
that are associated with inflammation and tissue remodeling, such as in the sera and joints 
of arthritis patients [28]. Recently, the activity of TSG-6 in osteoarthritis synovial fluid 
has been demonstrated as a biomarker for OA progression and the need for knee 
replacement [29]. TSG-6 has a diversity of functions. It has been described to inhibit 
neutrophil migration [30], has anti-inflammatory effects as it is considered 
chondroprotective in murine model of arthritis [31], and has a major role in stabilization 
of the HA matrix of the cumulus cell-oocyte complexes that is crucial for fertility [32]. 
Further, TSG-6 expression is among the genes upregulated > 4 fold in allergen-
challenged patients as shown in [Table 2] emphasizing the important role that TSG-6 has 
also during inflammation [33]. It has been shown that TSG-6 catalyzes the transfer of 
HCs from the C4S chain to the N-acetyl-glucosamine (glcNAc) residues on the HA to 
form HC-HA complexes that have been implicated in many pathological responses. HC-
HA complexes have been shown to accumulate within inflamed tissues and correlate with 
disease severity [34,35]. During many pathological processes, these HC-HA matrices 
contain structural information recognized by mononuclear leukocytes potentially 
explaining the increased leukocyte binding [36,37]. 
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Table 2. Bronchial Epithelial Cell mRNAs with Fourfold or Greater Upregulated 
Expression after Allergen Challenge 
 
 
TSG6:
•  Following segmental allergen challenge of asthmatic individuals, TSG-6, in 
addition to the Th2 cytokines IL-3, IL-4 and IL-5, is one of 24 genes that are 
induced four fold or more. 
(Effects of Allergen Challenge on Airway Epith lial Cell Gene Expression Craig M. Lilly, Hiroki Tateno, Tsuyoshi Oguma, Elliot Israel, 
and Larry A. Sonna.  Am J Respir Crit Care Med Vol 171. pp 579–586, 2005.)
Title
Credits
     Asthma  
3
4
5
6
7
     Data
8
9
10
Summary 1
    TSG-6
12
13
14
     Data
15
16
17
18
19
20
21
Summary 2
Credits
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IV.2.3. Constitutive Expression of Heavy Chain Donors and TSG-6 
At the present time, the only well characterized source of IαI is in the serum being 
produced by the liver hepatocytes. Amniotic membrane (AM) is another tissue in 
addition to the liver that constitutively produces IαI. The HC1-HA complex made by this 
tissue is different from that found at inflammatory sites (e.g. in asthma and arthritis) that 
potentially could explain for the anti-inflammatory, anti-scarring, and anti-angiogenic 
actions of the AM [38].  
In this study we show that AECs can synthesize their own heavy chain donor as HC3-
bikunin that is used for the HC transfer onto the HA without the requirement of serum 
exudate that could occur during inflammation. This donor is the same as, the pre-IαI 
made and secreted by renal epithelium, which is also composed of a bikunin with a HC3 
covalently linked by an ester bond to the chondroitin-4-sulfate chain [39]. AECs can also 
constitutively express TSG-6 without being stimulated with TNFα as shown is the results 
section VI.4. 
 
 
 
 
 
 
 
 
	  	  	   70	  
 
 
IV.3. MATERIALS AND EXPERIMENTAL PROCEDURES 
 
 
 
IV.3.1. Mice 
 
As described in section II.3.2.  
 
IV.3.2. Primary Cell Culture 
 
As described in section II.3.4. 
 
IV.3.3. Cell Lysate Preparation  
 
 
200 µL of cold cell lysis buffer (1% Triton X-100, 40 mM HEPES, of pH 7.4, 300 mM 
NaCl, 3 mM MgCl2, 4 mM EGTA), with protease (Complete Mini, 11826153001; Roche 
Applied Science) and phosphatase (PhosSTOP, 04906845001, Roche Applied Sciences) 
inhibitors, was added to the AECs cultured on transwell inserts at day 10 of their 
differentiation. The AECs were lysed by pipetting the added volume of lysis buffer up 
and down, and avoiding the formation of air bubbles as much as possible. The volume of 
lysis buffer added was left on the transwell insert for 40 minutes on ice before it was 
collected and spun down by centrifugation for 10 minutes at 14,000 g and at 4o C. The 
supernatant was transferred to a new 1.5 mL eppendorf tube and then stored at -80o C till 
the time of use. The samples were then processed for Western Blotting as described in 
section IV.3.5.  
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IV.3.4. Basement Membrane Protein Extraction 
 
900 µL of 4x Laemmli Sample Buffer (161-0747; BioRad) was mixed with 100 µl β-
mercaptoethanol (BME) (161-0710; BioRad). 200 µl of this mix was added to one 
transwell insert, which was has a pre-deposited basement membrane by MDCK cells as 
described in section II.3.3. Extraction of the proteins of the basement membrane was 
done by pipetting up and down the added volume of the sample buffer 3 times, before 
transferring the same volume of sample buffer to the next transwell insert. This was 
repeated to extract the proteins from a total number of 12 transwell inserts in a total 
volume of 200 µL sample buffer with a final protein concentration of nearly 25 µg. This 
was run on a gel as described in section IV.3.5, and stained for HC-3 and TSG-6 protein 
detection as described in section IV.3.6 for protein detection on gel by Coomassie blue 
staining. 
 
IV.3.5. Western Blot Analysis  
Samples were electrophoresed on 4-5% Mini-PROTEAN TGX gels (456-8084; BioRad) 
and blotted using PVDF membranes (170-4156 – PVDF mini; BioRad) and the Trans-
Blot Turbo System. All blots were blocked for 1 h with 5% milk (Blotting Grade 
Blocker,170-6404; BioRad) and probed overnight at 4° C with antibodies against HC1 
(SC-33944; Santa Cruz Biotechnology), HC2 (SC-21978; Santa Cruz Biotechnology), 
HC3 (SC- 21979; Santa Cruz Biotechnology), and bikunin (a kind gift from Anthony 
Day, University of Manchester, UK). Blots were washed with 1X Tris Buffered Saline 
(TBS) with TWEEN®20 (0777-2 L; AMRESCO) 3 times for 7 minutes each time. Blots 
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were incubated with secondary antibody, and Biotin-SP-conjugated donkey anti-goat IgG 
was used as secondary antibody (705-065-147; Jackson ImmunoResearch), against 
primary antibodies against HC1-3 for 1 h at room temperature. Blots were washed again 
with 1X TBS with TWEEN®20 3 times for 7 minutes each time before the incubation 
with streptavidin-horse radish peroxidase (HRP) (P0397; Dako Cytomation) for 1 h at RT 
Blots were washed again with 1X TBS with TWEEN®20 3 times for 7 minutes each 
time.  
TSG-6 was assessed using a biotinylated anti-mouse TSG-6 antibody (BAF2326; R&D 
systems, Inc.). Recombinant mouse TSG-6 (2326-TS; R&D systems, Inc.) was used as a 
positive control for the TSG-6 antibody. All blots were developed using the ECL Prime 
Western Blotting Detection Reagent (RPN2232, Amersham).  
 
IV.3.6. Coomassie Blue Staining 
 
The protein extracts of the basement membrane, deposited by the MDCK cells, were 
electrophoresed on 4-5% Mini-PROTEAN TGX gels (456-8084; BioRad). The gel was 
washed with distilled water for 10 minutes and then stained with Bio-Safe Coomassie 
Stain (161-0786; BioRad) overnight.  The gel was washed with distilled water every 10 
minutes for 30 minutes before it was visualized using myECL imager from Thermo 
Scientific.  
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IV.3.7. PCR Analyses  
 
 
RNA was isolated using the RNAeasy kit (74104; Qiagen), and cDNA was prepared 
using Superscript @ First-Strand Synthesis System (11904-018; Invitrogen).	    Primers 
used are listed in (Table 3) below. The PCR conditions were 1 cycle at 94° C for 3 min, 
40 cycles of 95° C for 30 sec, 55° C for 45 sec, 72° C for 1 min, followed by 1 cycle of 
72° C for 1 min. These conditions were used for all primers. PCR products were run on 
3% ethidium bromide gels (E1510; Sigma) and 1% agarose gels (SeaKem® HGT 
Agarose, product 50041; Lonza). 
 
 
Name of Primers Primer Sequence Expected PCR product 
!-actin  5’-GGTCATCACTATTGGCAACG-3’  
5’-ACGGATGTCAACGTCACACT-3’  
133 bp 
Heavy chain 1 5’TTCTCAGCCCTTAGAGATGGTG’3 
5’-GAGTGGCAACTTTGAGTCTATGG-3’   
100 bp 
Heavy Chain 2 5’-GGTGATAGAGAATGATGCTGGA-3’  
5’-CAACCTTGGTGCCATAATACAG-3’  
101 bp 
Heavy Chain 3 5’- CCCAGAAAGATTACAGGAAGGA-3’  
5’-TCGGTATGGACACCATCAATTA- 3’  
100 bp 
TSG-6  5’- CTCCATATGGCTTGAACAAGCAGC- 
3’  
5’- ACCACCTTCAAATTCACATACG- 3’  
112 bp  
Table 3. The Sequences of the Polymerase Chain Reaction (PCR) Amplification Primers  
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IV.4. RESULTS AND DISCUSSION 
 
 
IV.4.1. Murine AECs make their own heavy chain3 (HC3) donor as HC3-bikunin 
ΙαΙ is a proteoglycan that normally contains two HCs (HC1 and HC2). It is produced by 
the liver hepatocytes where it is released into the serum at relatively high concentrations. 
It serves as a HC donor for TSG-6 mediated transfer of HCs to HA during many 
inflammations. The AEC culture medium lacks serum, the source of ΙαΙ, which is the 
source of HCs. Therefore, the presence of HC-HA in the HA rafts from unstimulated 
AEC cultures suggests that AECs can make their own HC donor.  From the three 
different HC subtypes (HC1-3) analyzed by RT-PCR, murine AECs express only HC3, as 
shown in [Fig. 21A]. [Fig. 21B] shows that the donor, which has a MW of ~132 kDa, 
contains HC3 and bikunin, which is equivalent to the pre-IαI complex. This donor is the 
same as the pre-IαI made and secreted by renal epithelium, which is composed of a 
bikunin with a HC3 covalently linked by an ester bond to the chondroitin-4-sulfate chain 
[9-16]. Therefore, AECs synthesize their own HC3-bikunin, in a manner similar to renal 
epithelial cells, and are able to generate HC3-HA rafts without the requirement of a 
serum exudate produced during inflammations.  
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Fig. 21. Murine AECs make their Own Heavy Chain 3 (HC3) Donor as HC3-
Bikunin, a Member of the PαI/IαI family. (A) PCR products produced using primers 
for the 3 heavy chain subtypes (HC1-3 as listed in Table 3), were prepared from mRNA 
isolated from day 10 unstimulated murine AECs, and then separated on a 1% agarose gel 
and stained with 3% eithidium bromide. β-actin mRNA production was used as the 
housekeeping gene. One representative gel of 3 is shown. (B) Western blots of AEC 
lysates demonstrate the presence of HC3 protein using a HC3 antibody (blot on the left). 
Western blots with antisera to HC1 and HC2 were negative (data not shown). A 
biotinylated secondary antibody (1:5000 dilution) was used after the primary antibody 
application followed by a streptavidin-HRP (1:2000 dilution). The detected band has a 
molecular weight of 132 kDa, equivalent to that of PαI (with one HC) of the IαI (with 
two HCs) family. The blot in the right also labeled the 132 MW band when it was probed 
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with an antibody to bikunin, the core protein of IαI, providing evidence for the pre-IαI 
member of the family that is HC3-bikunin. 
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IV.4.2. TSG-6 is expressed by unstimulated murine AECs and released apically and 
not basally.  
 
The HC3-HA data in figures 5 and 6 provide evidence that AECs synthesize TSG-6 as 
well as their own HC3-bikunin. Therefore, we isolated total cellular RNA isolated from 
day 10 differentiated AECs and examined TSG-6 mRNA by RT-PCR.  We used cellular 
RNA isolated from mouse dermal fibroblasts, known to express TSG-6 only when treated 
with TNFα [38], as our positive control [Fig. 22A]. Furthermore, we analyzed Western 
blots of apical washes and basal media of AEC cultures for TSG-6 protein levels as 
probed with a biotinylated mouse TSG-6 antibody. This antibody detected the 
recombinant mouse TSG-6 at the expected molecular weight ~35 kDa [Fig. 22B].  
However, a larger band (~65 kDa) was detected in the apical washes of AECs [Fig. 22B].  
No band was detected in the basal medium, which indicates that neither the defined 
culture medium nor basally secreted products from the AECs contain reactive bands.  The 
~60 kDa band was present in the apical washes from WT AECs but absent in the apical 
washes of TSG-6 null AECs [Fig. 17B], indicating that the antibody is likely detecting 
TSG-6 in a dimerized form. Therefore, AECs can express TSG-6 on both transcriptional 
[Fig. 22A] and translational level [Fig. 22B, Fig. 17B]. 
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Fig. 22. AECs produce TSG-6 Apically that is required for the HC3-HA Complex 
Formation.   (A) TSG-6 expression of a 10 day murine AECs is shown by the ethidium 
bromide stained PCR product of TSG-6 separated on a 1% agarose gel and by 
comparison to murine extracts of dermal fibroblast cultures treated with TNFα, using β-
actin as the housekeeping gene. (B) Western blot of basal medium and apical washes of a 
10 day AEC culture were probed with an antibody against TSG-6 that can also detect the 
murine recombinant TSG-6 (mrTSG-6) used as a positive control.   
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IV.4.3. Basement membrane deposited by MDCK cells contains neither TSG-6 nor 
HC3 
We also analyzed the basement membrane deposited by MDCK cells that the AECs are 
cultured on during their differentiation, by Western blotting for HC3 and TSG-6 protein 
levels since MDCK cells are also kidney epithelial cells. Protein levels of HC3 and TSG-
6 were not detected as shown in [Fig. 23] confirming that the source of these two proteins 
is from the AECs and not the basement membrane, and that the proteins found in the 
basement membrane are not interfering with the method of detection of the antibodies 
used in this study.  
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Fig. 23. Basement Membrane Deposited by MDCK Cells does not contain 
Detectable Levels of HC3 or TSG-6. (A) Western blot of protein extracts of the 
basement membrane synthesized by the MDCK cells on the transwells probed with 
antibodies against TSG-6 (lane 2) and HC-3 (lane 3) with recombinant TSG-6 (lane 1) as 
a positive control for the TSG-6 antibody used.  (B) Gel of protein extracts of the 
deposited basement membrane by the MDCK cells stained with Coomassie Blue stain for 
protein detection. 
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     CHAPTER V 
 
 
CONCLUDING REMARKS 
 
HA can be uniquely modified during inflammation by the transfer of HCs from IαI to 
form HC-HA complexes mediated by TSG-6. HC-HA matrices are leukocyte adhesive as 
demonstrated in many pathological conditions. Further, TSG-6 has an essential role in 
normal biology because the lack of the TSG-6 mediated HC-HA matrix in normal 
cumulus cell-oocyte complexes causes female infertility in TSG-6-/- female mice [1].  
This demonstrates that HC-HA matrices can be part of a normal extracellular matrix as 
well as an inflammatory response to stimuli.  
Unlike any other cell type reported so far, AECs uniquely release leukocyte-adhesive 
HC3-HA complexes from their apical surface into their extracellular space even in the 
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absence of inflammatory stimuli. These HC3-HA rafts were not only observed in the 
air/liquid AEC culture model but also in the bronchoalveolar lavage of naïve mice 
implying that these rafts are part of murine normal secretions and can have a role as a 
host defense mechanism.  
Leukocyte adhesion to HA rafts was also observed to a lesser extent in the absence of a 
TSG-6 mediated HC transfer suggesting that HC attachment to the HA raft is not the sole 
explanation for leukocyte binding. This adhesion could be due to the involvement of 
other HA binding proteins that could be further investigated or, similar to HA cables 
formed without HC addition, HA rafts could bind leukocytes even in the absence of 
binding proteins such as HCs [2]. 
In this study, we show that murine AECs can synthesize their own heavy chain donor as 
pre-IαI complex of HC3 and bikunin, which was previously reported to be constitutively 
expressed by human proximal tubular epithelial cells (PTECs) [3]. Furthermore, we also 
show that murine AECs constitutively express TSG-6 as do PTECs. However, in this 
study the production of HC3-bikunin and TSG-6 by human PTECs was investigated in 
the context of their contribution to the pathogenesis of renal fibrosis. At present it is 
unclear whether PTECs behave in a similar manner as AECs by forming HA rafts. 
Because both cell types have a similar cell lineage, this would be worth investigating in 
the future.  
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The study by Forteza et al. [4] also provided evidence that normal human epithelial cell 
cultures have low levels of mRNA for TSG-6, bikunin and HC3, which were increased 
moderately by treatment with TNF-α. This study also showed that epithelia in sections of 
trachea from smokers showed increased staining for IαI and bikunin compared with 
normal tracheal sections.  This provides evidence that human airway epithelia may also 
normally make HC3-HA rafts, which are amplified during inflammatory processes such 
as smoking and asthma. 
Furthermore, we have developed a culture model where AECs are cultured on a 
basement membrane deposited by MDCK cells. This basement membrane closely 
resembles the one in vivo and results in an airway epithelium that resembles its 
counterpart in vivo. The presence of a basement membrane allows primary cells to 
polarize and differentiate, in this case, into pseudotratified ciliated epithelial cells. This 
unique culture model has the potential to become a widely used tool not only for 
culturing AECs but also for other primary cell types such as Human Umbilical Vein 
Epithelial Cells (HUVECs). 
Airway Epithelium is one of our first lines of defense that provides both a chemical and a 
physical barrier. A lot of studies have shown the responsiveness of the AECs to external 
pathogenic attack by the release of different cytokines. We have demonstrated that these 
cells are also equipped with HA rafts because they can make their HC donor and TSG-6, 
and it would be interesting to investigate their contribution during inflammation and their 
effect on subjacent cells.  We have developed a co-culture system that uses our model of 
culturing AECs to investigate the cross-talk between AECs and ASMCs as shown in 
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[Fig. 24]. We can also extend our investigation to include AECs from different knock-out 
mice for proper dissection of the different pathways involved.  
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Fig. 24. A Schematic Illustration of the Use of Co-culture Model in Investigating the 
Cross-Talk between AECs and ASMCs. 
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In summary, this study provides the first description of leukocyte-adhesive HA rafts 
located in the extracellular space on murine AEC apical surfaces.  This unique release 
mechanism of HA rafts defines the HC-HA complex as a previously unidentified 
component of respiratory secretions. Murine HA rafts are identified as HC3-HA 
complexes that AECs can make in the absence of inflammatory stimuli. Thus, HA rafts 
perhaps serve as a broad anchor for leukocytes at the airway surface ready to be utilized 
upon a pathogenic attack or could be an anchor to other proteins and enzymes that might 
be involved in a host defense mechanism [6]. Therefore, this study fills important gaps in 
our current understanding of murine airway epithelial biology and secretions that relate to 
human health and disease. 
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APPENDIX A 
KDEL 
KDEL The abbreviation KDEL is formed by the corresponding letters to each amino 
acid, K for Lysine, D for Aspartic acid, E Glutamic acid, L for Leucine.   
KDEL is a sequence in the amino acid structure of a protein which keeps it from being 
secreted from the endoplasmic reticulum (ER). Proteins can only leave the ER after this 
sequence has been cleaved off. It is accumulation in the ER is indicative of an ER stress.  
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APPENDIX B 
CD44 “ Capping” 
The presence of HA cables at sites of tissue inflammation can still function as an anti- 
inflammatory polymer. Monocytes adhere tightly to the HA cables regardless of their 
activation state, and following adhesion the dis- tribution of CD44 on the monocyte cell 
surface polarizes to form a “cap” while a portion of the HA cable is internalized. 
 
Fig 25. Capping of CD44 on leukocytes. (A) Monocytes bind to HA cables (green) 
produced by SMC in response to poly I:C. CD44 (red) is dispersed on the monocyte 
surface. (B) After 15 min incubation at 37°C, CD44 (red) is capped to one pole on the 
leukocytes, HA cables appear ragged (center panel) and HA is internalized. (Nuclei are 
blue).  
[Day AJ, de la Motte CA. Hyaluronan cross-linking: a protective mechanism in 
inflammation? Trends Immunol. 2005; 26(12):637–43]. 
